Oncology RWE

Richer Oncology Insights with SVMPharma

Utilise SVMPharma’s expertise and unique oncology dataset to deliver the outcomes that matter in cancer care. Discover unique insights to support your R&D, HEOR/drug safety and commercial teams.

  • Anonymous patient level data
  • Demonstrate value
  • Discover real world clinical practice
  • Understand unmet needs
  • Monitor brand performance and new product uptake
  • Deliver outcomes that matter

Get the whole picture: Patient level data from diagnosis through the treatment journey

SVMPharma RWE captures the whole patient journey to develop a deep and accurate understanding of real world cancer care. Our outcomes can help support clinically appropriate utilisation of patient therapies and enhance research and drug development efforts.

SACT vs. Oncology Electronic Prescribing Records

The NHS has mandated electronic chemotherapy prescribing within the NHS.

With electronic records we can identify, extract and analyse large amounts of longitudinal data from electronic medical records and support our customers with well performed analyses of the real world data we capture.

SVMPharma’s RWE studies are one step ahead of the Systemic Anti Cancer Therapy (SACT) data set.

SACT

doctor1

Diagnosis

Patient demographics Comorbidities Date of diagnosis Risk factors

treatment2

Treatment

Treatment history Disease markers Healthcare visits Dosing schedule Resource utilisation

followup3

Follow up

Clinical endpoints Progression markers Overall survival Progression free survival

 

SVMPharma: Specialists in Oncology

SVMPharma have over 20 years’ experience in oncology and have undertaken a number of Real World Evidence projects in a variety of tumour sites. Find out more about our Real World Evidence Outcomes here.